Literature DB >> 17925367

Neuropathology for the neuroradiologist: plaques and tangles.

F J Wippold1, N Cairns, K Vo, D M Holtzman, J C Morris.   

Abstract

Histologically identified intracellular and extracellular inclusions and structures often provide a tissue diagnosis of a specific disease process. Moreover, these deposits may provide clues about the pathogenesis of the disease in which they are found. Two distinctive structures seen within the brains of patients clinically diagnosed with dementia of the Alzheimer type are extracellular plaques and intracellular neurofibrillary tangles. The purpose of this report is to review the significance of plaques and neurofibrillary tangles in the context of Alzheimer disease.

Entities:  

Mesh:

Year:  2007        PMID: 17925367      PMCID: PMC8119079          DOI: 10.3174/ajnr.A0781

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  51 in total

1.  Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

Authors:  J L Price; J C Morris
Journal:  Ann Neurol       Date:  1999-03       Impact factor: 10.422

Review 2.  Molecular imaging in Alzheimer's disease.

Authors:  Christopher Lascola
Journal:  Neuroimaging Clin N Am       Date:  2005-11       Impact factor: 2.264

Review 3.  Tauopathies: recent insights into old diseases.

Authors:  Andre Delacourte
Journal:  Folia Neuropathol       Date:  2005       Impact factor: 2.038

Review 4.  Aging of the brain, entropy, and Alzheimer disease.

Authors:  David A Drachman
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

Review 5.  Positron emission tomography diagnosis of Alzheimer's disease.

Authors:  R Edward Coleman
Journal:  Neuroimaging Clin N Am       Date:  2005-11       Impact factor: 2.264

Review 6.  Alois Alzheimer and Alzheimer's disease: a centennial perspective.

Authors:  David H Small; Roberto Cappai
Journal:  J Neurochem       Date:  2006-11       Impact factor: 5.372

7.  Alois Alzheimer (1864-1915). I. Contributions to neurology and psychiatry.

Authors:  W L Brannon
Journal:  J S C Med Assoc       Date:  1994-09

Review 8.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Progressive neuronal injury associated with amyloid plaque formation in Alzheimer disease.

Authors:  J G Sheng; X Q Zhou; R E Mrak; W S Griffin
Journal:  J Neuropathol Exp Neurol       Date:  1998-07       Impact factor: 3.685

10.  Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease.

Authors:  J Lowe; A Blanchard; K Morrell; G Lennox; L Reynolds; M Billett; M Landon; R J Mayer
Journal:  J Pathol       Date:  1988-05       Impact factor: 7.996

View more
  9 in total

Review 1.  Multimodality Review of Amyloid-related Diseases of the Central Nervous System.

Authors:  Michelle M Miller-Thomas; Adam L Sipe; Tammie L S Benzinger; Jonathan McConathy; Sarah Connolly; Katherine E Schwetye
Journal:  Radiographics       Date:  2016 Jul-Aug       Impact factor: 5.333

Review 2.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2015-01-07       Impact factor: 5.590

3.  Modulating microenvironments for treating glioblastoma.

Authors:  LaDeidra Monet Roberts; Jennifer Munson
Journal:  Curr Tissue Microenviron Rep       Date:  2020-08-13

4.  Label-Free Infrared Spectroscopic Imaging Reveals Heterogeneity of β-Sheet Aggregates in Alzheimer's Disease.

Authors:  Matthew P Confer; Brooke M Holcombe; Abigail G Foes; John M Holmquist; Savannah C Walker; Sanghamitra Deb; Ayanjeet Ghosh
Journal:  J Phys Chem Lett       Date:  2021-09-30       Impact factor: 6.475

5.  Anti-amyloidogenic indolizino[3,2-c]quinolines as imaging probes differentiating dense-core, diffuse, and coronal plaques of amyloid-β.

Authors:  Kyeonghwan Kim; Jeong Hwa Lee; Sunmi Kim; Songmin Lee; Donghee Lee; Hye Yun Kim; Ikyon Kim; YoungSoo Kim
Journal:  RSC Med Chem       Date:  2021-10-11

6.  Amyloid β and tau pathology in brains of aged pinniped species (sea lion, seal, and walrus).

Authors:  Yuta Takaichi; James K Chambers; Kei Takahashi; Yoshiyuki Soeda; Riki Koike; Etsuko Katsumata; Chiaki Kita; Fuko Matsuda; Makoto Haritani; Akihiko Takashima; Hiroyuki Nakayama; Kazuyuki Uchida
Journal:  Acta Neuropathol Commun       Date:  2021-01-07       Impact factor: 7.801

7.  Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.

Authors:  Yi-Wen Bao; Anson C M Chau; Patrick Ka-Chun Chiu; Yat Fung Shea; Joseph S K Kwan; Felix Hon Wai Chan; Henry Ka-Fung Mak
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 8.  Extracellular protein components of amyloid plaques and their roles in Alzheimer's disease pathology.

Authors:  M Mahafuzur Rahman; Christofer Lendel
Journal:  Mol Neurodegener       Date:  2021-08-28       Impact factor: 14.195

9.  Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy.

Authors:  Jaren W Landen; Sharon Cohen; Clare B Billing; Carol Cronenberger; Scot Styren; Aaron H Burstein; Catherine Sattler; Jae-Hong Lee; Clifford R Jack; Kejal Kantarci; Pamela F Schwartz; William T Duggan; Qinying Zhao; Ken Sprenger; Martin M Bednar; Brendon Binneman
Journal:  Alzheimers Dement (N Y)       Date:  2017-05-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.